Author

Samuel Jesús Martínez-Domínguez

INCREASED PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN LEAN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
INCREASED PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN LEAN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE

Samuel Jesús Martínez-Domínguez  et al.

ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Samuel Jesús Martínez-Domínguez  et al.

NAFLD AND LIVER FIBROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A CASE-CONTROL STUDY
NAFLD AND LIVER FIBROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A CASE-CONTROL STUDY

Samuel Jesús Martínez-Domínguez  et al.

NAFLD AND LIVER FIBROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A CASE-CONTROL STUDY
NAFLD AND LIVER FIBROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A CASE-CONTROL STUDY

ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ERRORS IN EMPIRICAL ANTIBIOTIC THERAPIES FOR HELICOBACTER PYLORI ERADICATION IN 45,778 PATIENTS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

ANEMIA IS ASSOCIATED WITH POOR PROGNOSIS IN PATIENTS TREATED WITH DUAL ANTI-PLATELET THERAPY AFTER CARDIAC CATHETERIZATION
ANEMIA IS ASSOCIATED WITH POOR PROGNOSIS IN PATIENTS TREATED WITH DUAL ANTI-PLATELET THERAPY AFTER CARDIAC CATHETERIZATION

Samuel Jesús Martínez-Domínguez  et al.

BEING YOUNG AND WOMEN ARE RISK FACTORS FOR MALNUTRITION ACCORDING TO GLIM CRITERIA IN INFLAMMATORY BOWEL DISEASE OUTPATIENS
BEING YOUNG AND WOMEN ARE RISK FACTORS FOR MALNUTRITION ACCORDING TO GLIM CRITERIA IN INFLAMMATORY BOWEL DISEASE OUTPATIENS

Samuel Jesús Martínez-Domínguez  et al.

METABOLIC ASSOCIATED LIVER DISEASE AND SEX AS KEY FACTORS OF CARDIOVASCULAR RISK IN INFLAMMATORY BOWEL DISEASE
METABOLIC ASSOCIATED LIVER DISEASE AND SEX AS KEY FACTORS OF CARDIOVASCULAR RISK IN INFLAMMATORY BOWEL DISEASE

Samuel Jesús Martínez-Domínguez  et al.

EVALUATION OF THE ACCURACY OF THE "LIAISON(R) MERIDIAN HELICOBACTER PYLORI SA" STOOL ANTIGEN TEST FOR THE DIAGNOSIS OF H. PYLORI INFECTION: A SPANISH MULTICENTRE STUDY
EVALUATION OF THE ACCURACY OF THE "LIAISON(R) MERIDIAN HELICOBACTER PYLORI SA" STOOL ANTIGEN TEST FOR THE DIAGNOSIS OF H. PYLORI INFECTION: A SPANISH MULTICENTRE STUDY

Samuel Jesús Martínez-Domínguez  et al.

RECURRENCE PATTERNS AFTER FIRST SYMPTOMATIC GALLSTONE ADMISSION. WHO MUST BE PRIORITIZED ON THE CHOLECYSTECTOMY WAITING LIST? RELAPSTONE, AN AEG YOUNG TALENT GROUP MULTICENTER STUDY
RECURRENCE PATTERNS AFTER FIRST SYMPTOMATIC GALLSTONE ADMISSION. WHO MUST BE PRIORITIZED ON THE CHOLECYSTECTOMY WAITING LIST? RELAPSTONE, AN AEG YOUNG TALENT GROUP MULTICENTER STUDY

Samuel Jesús Martínez-Domínguez  et al.

EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 6,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 6,000 PATIENTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Samuel Jesús Martínez-Domínguez  et al.

EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 8,000 PATIENTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
EXPERIENCE WITH SINGLE-CAPSULE BISMUTH QUADRUPLE THERAPY IN 8,000 PATIENTS FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Samuel Jesús Martínez-Domínguez  et al.

PRESCRIPTION PATTERN OF PROBIOTICS AS AN ADJUVANT THERAPY FOR HELICOBACTER PYLORI ERADICATION: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
PRESCRIPTION PATTERN OF PROBIOTICS AS AN ADJUVANT THERAPY FOR HELICOBACTER PYLORI ERADICATION: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

Samuel Jesús Martínez-Domínguez  et al.

THE ROLE OF PROBIOTICS IN THE EFFECTIVENESS OF TREATMENT AGAINST HELICOBACTER PYLORI: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
THE ROLE OF PROBIOTICS IN THE EFFECTIVENESS OF TREATMENT AGAINST HELICOBACTER PYLORI: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

Samuel Jesús Martínez-Domínguez  et al.

IMPACT OF PROBIOTICS USE ON THE SAFETY OF HELICOBACTER PYLORI TREATMENTS: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
IMPACT OF PROBIOTICS USE ON THE SAFETY OF HELICOBACTER PYLORI TREATMENTS: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

Samuel Jesús Martínez-Domínguez  et al.

Item 1 - 15 / 15
1